Spin-off dividend tax info posted by AnaptysBio (NASDAQ: ANAB)
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
AnaptysBio, Inc. is providing tax information to its stockholders about the dividend they received from the separation and spin-off of First Tracks Biotherapeutics, Inc. The company has filed IRS Form 8937 and is making the same information available in the Investors section of its website.
The Form 8937 explains how the spin-off dividend is treated for tax purposes and how stockholders should determine their adjusted tax basis. AnaptysBio emphasizes that this material is for informational purposes only and urges stockholders to consult their own tax advisors about their specific situations.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 7.01 — Regulation FD Disclosure
1 item
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Key Figures
8-K signature date: May 29, 2026
1 metrics
8-K signature date
May 29, 2026
Date the report was signed by the Chief Financial Officer
Key Terms
Form 8937, spin-off, dividend, tax basis, +1 more
5 terms
Form 8937 regulatory
"The Form 8937 provides information about the dividend received by stockholders"
Form 8937 is a U.S. Internal Revenue Service disclosure companies file to explain how a corporate action—like a merger, spin-off, or stock split—changes the tax cost (tax basis) of an investor’s shares. It matters because that tax cost determines how much profit or loss you report when you sell, so the form is like an instruction sheet showing how to split or adjust the original purchase price for tax reporting.
spin-off financial
"resulting from the separation and spin-off of First Tracks Biotherapeutics, Inc."
A spin-off happens when a company creates a new, independent business by separating part of itself, like splitting off a division into its own company. This often happens so the new company can focus better on its own goals or attract different investors. It matters because it can lead to more growth opportunities and clearer focus for both companies.
dividend financial
"information about the dividend received by stockholders resulting from the separation"
A dividend is a payment that a company gives to its shareholders, usually from its profits. It’s like a bonus or reward for owning the company's stock, and it can provide a steady income stream for investors. Companies pay dividends to share their success with the people who own their stock.
tax basis financial
"how the dividend is treated by the Company’s stockholders and how the change in tax basis is determined"
Tax basis is the original value assigned to an asset for tax purposes, adjusted over time for things like improvements, depreciation, or distributions; it serves as the starting point used to calculate gain or loss when the asset is sold. For investors, it determines how much of a sale is treated as taxable profit—think of it as the purchase price on a receipt you subtract from the selling price to see what portion is taxed, so a higher basis usually means a smaller tax bill.
Regulation FD Disclosure regulatory
"Item 7.01 Regulation FD Disclosure."
Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.
FAQ
What did AnaptysBio (ANAB) announce in this 8-K filing?
AnaptysBio announced that it has filed IRS Form 8937 and will post related information on its website. The form explains tax treatment of the dividend from the First Tracks Biotherapeutics spin-off for AnaptysBio stockholders.
What is the purpose of AnaptysBio’s IRS Form 8937 regarding First Tracks Biotherapeutics?
The Form 8937 provides details on the dividend received from the First Tracks Biotherapeutics spin-off. It explains how the dividend is treated for tax purposes and how stockholders should determine changes to their tax basis in the related shares.
Where can AnaptysBio (ANAB) investors find the Form 8937 tax information?
Investors can access the Form 8937 information in the Investors section of AnaptysBio’s website. The company has also filed the form with the IRS, making the same explanatory tax details available to stockholders online for reference.
Does AnaptysBio’s Form 8937 replace personalized tax advice for ANAB stockholders?
No. AnaptysBio states the Form 8937 information is for informational purposes only. The company urges stockholders to consult their own tax advisors about the First Tracks dividend, including potential state, local, and non-U.S. tax consequences.